Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response (Q43041800)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2008
edit
Language Label Description Also known as
English
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
scientific article published in January 2008

    Statements

    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response (English)
    Olav Dalgard
    Kristian Bjøro
    Helmer Ring-Larsen
    Einar Bjornsson
    Mona Holberg-Petersen
    Eva Skovlund
    Olle Reichard
    Bjørn Myrvang
    Bo Sundelöf
    Ståle Ritland
    Kjell Hellum
    Aril Frydén
    Jon Florholmen
    Hans Verbaan
    North-C Group
    1 January 2008
    35-42

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit